Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313339946> ?p ?o ?g. }
- W4313339946 endingPage "275" @default.
- W4313339946 startingPage "257" @default.
- W4313339946 abstract "Inhibiting individual histone deacetylase (HDAC) is emerging as well-tolerated anticancer strategy compared with pan-HDAC inhibitors. Through preclinical studies, we demonstrated that the sensitivity to the leading HDAC6 inhibitor (HDAC6i) ricolinstat can be predicted by a computational network-based algorithm (HDAC6 score). Analysis of ~3,000 human breast cancers (BCs) showed that ~30% of them could benefice from HDAC6i therapy. Thus, we designed a phase 1b dose-escalation clinical trial to evaluate the activity of ricolinostat plus nab-paclitaxel in patients with metastatic BC (MBC) (NCT02632071). Study results showed that the two agents can be safely combined, that clinical activity is identified in patients with HR+/HER2− disease and that the HDAC6 score has potential as predictive biomarker. Analysis of other tumor types also identified multiple cohorts with predicted sensitivity to HDAC6i’s. Mechanistically, we have linked the anticancer activity of HDAC6i’s to their ability to induce c-Myc hyperacetylation (ac-K148) promoting its proteasome-mediated degradation in sensitive cancer cells. Silva and colleagues develop a network-based HDAC6 score which could predict sensitivity to the HDAC6 inhibitor ricolinstat in preclinical models, as well as patients with HR+/HER2− breast cancer that received ricolinstat in a phase 1b clinical trial." @default.
- W4313339946 created "2023-01-06" @default.
- W4313339946 creator A5001207671 @default.
- W4313339946 creator A5001624199 @default.
- W4313339946 creator A5005061089 @default.
- W4313339946 creator A5006730060 @default.
- W4313339946 creator A5007832267 @default.
- W4313339946 creator A5010601661 @default.
- W4313339946 creator A5013486666 @default.
- W4313339946 creator A5017756904 @default.
- W4313339946 creator A5023689602 @default.
- W4313339946 creator A5037142172 @default.
- W4313339946 creator A5039985831 @default.
- W4313339946 creator A5041058568 @default.
- W4313339946 creator A5046245448 @default.
- W4313339946 creator A5048029720 @default.
- W4313339946 creator A5050543825 @default.
- W4313339946 creator A5051979453 @default.
- W4313339946 creator A5055781858 @default.
- W4313339946 creator A5056610138 @default.
- W4313339946 creator A5069875127 @default.
- W4313339946 creator A5070783771 @default.
- W4313339946 creator A5079519286 @default.
- W4313339946 creator A5080170238 @default.
- W4313339946 creator A5082136054 @default.
- W4313339946 creator A5089033254 @default.
- W4313339946 creator A5091028619 @default.
- W4313339946 creator A5091772334 @default.
- W4313339946 date "2022-12-30" @default.
- W4313339946 modified "2023-10-14" @default.
- W4313339946 title "Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer" @default.
- W4313339946 cites W1967789219 @default.
- W4313339946 cites W1970658265 @default.
- W4313339946 cites W1999240259 @default.
- W4313339946 cites W2005895632 @default.
- W4313339946 cites W2006617902 @default.
- W4313339946 cites W2019881443 @default.
- W4313339946 cites W2020471395 @default.
- W4313339946 cites W2025521110 @default.
- W4313339946 cites W2026465178 @default.
- W4313339946 cites W2027969289 @default.
- W4313339946 cites W2030185116 @default.
- W4313339946 cites W2031277429 @default.
- W4313339946 cites W2043398720 @default.
- W4313339946 cites W2043650582 @default.
- W4313339946 cites W2046405795 @default.
- W4313339946 cites W2050546395 @default.
- W4313339946 cites W2064959533 @default.
- W4313339946 cites W2065789246 @default.
- W4313339946 cites W2073911899 @default.
- W4313339946 cites W2074129822 @default.
- W4313339946 cites W2077813812 @default.
- W4313339946 cites W2079420389 @default.
- W4313339946 cites W2090926709 @default.
- W4313339946 cites W2095026025 @default.
- W4313339946 cites W2096283457 @default.
- W4313339946 cites W2096439168 @default.
- W4313339946 cites W2107823127 @default.
- W4313339946 cites W2109773179 @default.
- W4313339946 cites W2112678922 @default.
- W4313339946 cites W2120376568 @default.
- W4313339946 cites W2126821513 @default.
- W4313339946 cites W2130430382 @default.
- W4313339946 cites W2134602956 @default.
- W4313339946 cites W2138745251 @default.
- W4313339946 cites W2142739240 @default.
- W4313339946 cites W2155015733 @default.
- W4313339946 cites W2158501247 @default.
- W4313339946 cites W2162723598 @default.
- W4313339946 cites W2164461769 @default.
- W4313339946 cites W2167228337 @default.
- W4313339946 cites W2170913652 @default.
- W4313339946 cites W2188399911 @default.
- W4313339946 cites W2191939250 @default.
- W4313339946 cites W2419157048 @default.
- W4313339946 cites W2472255748 @default.
- W4313339946 cites W2499955277 @default.
- W4313339946 cites W2520638688 @default.
- W4313339946 cites W2559084827 @default.
- W4313339946 cites W2564862421 @default.
- W4313339946 cites W2569372699 @default.
- W4313339946 cites W2587008851 @default.
- W4313339946 cites W2589694786 @default.
- W4313339946 cites W2592811885 @default.
- W4313339946 cites W2597388148 @default.
- W4313339946 cites W2735132087 @default.
- W4313339946 cites W2791209104 @default.
- W4313339946 cites W2792323180 @default.
- W4313339946 cites W2806421539 @default.
- W4313339946 cites W2806469347 @default.
- W4313339946 cites W2884913978 @default.
- W4313339946 cites W2898963772 @default.
- W4313339946 cites W2899028298 @default.
- W4313339946 cites W2940861038 @default.
- W4313339946 cites W2968627637 @default.
- W4313339946 cites W2987236942 @default.
- W4313339946 cites W2996612587 @default.
- W4313339946 cites W3039401235 @default.